Category : Healthcare and Pharmaceuticals | Published at : September-2022 | Delivery Format : PDF | Status: Published | Pages : 250
The Global Orthopedic Biomaterials Market Size accounted for USD 17,289 Million in 2021 and is estimated to achieve a market size of USD 39,090 Million by 2030 growing at a CAGR of 9.7% from 2022 to 2030. The rising prevalence of musculoskeletal disorders and chronic skeletal situations is driving up product demand, fueling the growth of the orthopedic biomaterials market revenue. Furthermore, the growing geriatric population and increasing numbers of individuals opting for knee surgery, construction, as well as other joint-related orthopedic treatments are expected to drive the orthopedic biomaterials market growth in the coming years.
Orthopedic Biomaterials Market Report Key Highlights
- Global orthopedic biomaterials market value is estimated to expand by USD 39,090 million by 2030, with a 9.7% CAGR from 2022 to 2030
- According to the WHO, approx 1.71 billion individuals worldwide suffer from musculoskeletal conditions
- North America region accounting for around 36% of the global orthopedic biomaterials market share in 2021
- Asia-Pacific regional market is expected to grow at a CAGR of more than 11% during the forecast period
- By material type, the ceramics and bioactive glass segment accounted 31% revenue share in 2021
- The orthobiologics segment is expected to grow at a CAGR of 10.5% from 2022 to 2030
Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For many orthopedic apps, biomaterial systems are frequently referred to as' Implants.' These biomaterials assist to restore the structural integrity of the bone damaged by trauma or diseases. Prior to its use in orthopedic apps, the biocompatibility of the material is the main factor to consider. The selection of material, suitable structure, stabilization, and several properties, such as hardness, depends on the achievement of biomaterials in biological applications.
Global Orthopedic Biomaterials Market Dynamics
Market Drivers
- Increasing occurrences of musculoskeletal ailments
- Rising geriatric population across the worldwide
- Growing chronic skeletal circumstances
- a rise in the number of patients requiring knee replacement, restructuring, and other surgical procedures
Market Restraints
- High cost of orthopedic bio-implants & surgeries
- Various reimbursement scenarios
Market Opportunities
- Rising use of nanoparticles in orthopedic bio-implants
- Growing public awareness of orthopedic biomaterials
Orthopedic Biomaterials Market Report Coverage
| Market | Orthopedic Biomaterials Market |
| Orthopedic Biomaterials Market Size 2021 | USD 17,289 Million |
| Orthopedic Biomaterials Market Forecast 2030 | USD 39,090 Million |
| Orthopedic Biomaterials Market CAGR During 2022 - 2030 | 9.7% |
| Orthopedic Biomaterials Market Analysis Period | 2018 - 2030 |
| Orthopedic Biomaterials Market Base Year | 2021 |
| Orthopedic Biomaterials Market Forecast Data | 2022 - 2030 |
| Segments Covered | By Material Type, By Application, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | DePuy Synthes Inc., DSM Biomedical, Stryker Corp., Invibio Ltd., AdvanSource Biomaterials Corp., Zimmer Biomet, Globus Medical, Matexcel, Exactech, Inc., CAM Bioceramics B.V., Evonik Industries AG, and Heraeus Holding. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Orthopedic Biomaterials Market Insights
Increased incidence of musculoskeletal disorders and chronic skeletal disorders increases product demand and thus increases the orthopedic biomaterials market size. The growing geriatric population is anticipated to increase the demand further. This is extremely prone to these circumstances.
For example, in the United States the Census Bureau, aged 65 and older, has grown by 1,6 million between 2014 and 2015. Another factor that drives increasing demand for orthopedic biomaterials market trend is the increase in trauma instances resulting from accidents, fall, and sport. The risk of accidents increases as more and more individuals engage in sports and leisure operations.
In 2016, approximately 213 million Americans aged 6 years and older, for example, were involved in sports and fitness operations 2015, up from 209 million in 2014, according to National Health Statistical Reports. The development of this industry is also stepped up by the increasing amount of orthopedic surgeries such as joint arthroplasty. In addition, the development of the industry globally has been strengthened by the increased demand for next-generation orthopedic biomaterials tailored to satisfy the needs of a specific orthopedic procedure. On the other side, restricted coverage choices for reimbursement of orthopedic implants in several nations combined with decreasing reimbursement prevented market development. Further, a failure to reimburse producers has pressured them to reduce the prices for these products, which has reduced market growth.
Orthopedic Biomaterials Market Segmentation
The worldwide orthopedic biomaterials market segmentation is based on the material type, application, and geography.
Orthopedic Biomaterials Market By Material Type
- Calcium Phosphate Cements
- Ceramics & Bioactive Glasses
- Polymers
- Composites
- Metal
According to the orthopedic biomaterials industry analysis, the ceramics and bioactive glass segment will lead the global market in 2021. This growth is due to a rise in ceramic acceptance in the repair of difficult tissues in a variety of processes. On the other side, due to the comprehensive use of polymers as bone cement and cargo-bearing superficials for complete joint arthroplasties, the Polymer Segment is expected to be the fastest CAGR between 2019 and 2026. Moreover, the demand for polymers worldwide has risen with sophisticated polymers and biopolymers available for multiple applications such as orthobiological tissue fixation and bio-resorbable tissue fixation.
Orthopedic Biomaterials Market By Application
- Joint Replacement/Reconstruction
- Orthopedic Implants
- Viscosupplementation
- Bio-resorbable Tissue Fixation
- Orthobiologics
According to the orthopedic biomaterials market forecast, the orthopedic implants segment is dominating the market and is expected to remain in the forecast period. The increased incidences of disks and bone fractures in this sector and growing cases of trauma are anticipated to increase the demand for products. Due to the growing amount of bone repair and rebuilding operations around the world as a consequence of an increase in obesity and trauma, the orthhobiologics segment should be recording a rapid CAGR of about 10.5% over the forecast era. The figures released by the WHO state that approximately 1,3 million individuals are killed every year owing to traffic accidents worldwide and 93% of the total road deaths happen in middle and low-income nations.
Orthopedic Biomaterials Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
The Middle East & Africa (MEA)
- Gulf Cooperation Council (GCC)
- South Africa
- Rest of the Middle East & Africa
North America Region Is Expected To Dominate The Market
In 2021, North America dominated the market and is expected to further grow over the forecast period with a profitable CAGR. This increase is attributable to the increase in patients who require a knee replacement, rehabilitation, and other orthopedic procedures related to joints. The fast adoption of state-of-the-art products for bone void filling and implant load bearing is expected to further push the regional market. In addition, increased awareness amongst the population of biodegradable products, increasing health care costs as well as the increasing demand for sophisticated technological treatments and products, and increased public support are expected to increase the development of the North American market for orthopedic biomaterials. For example, in the United States in 2016, about 1,61,040 joint replacement procedures were reported under the American Joint Substitution Registry.
Europe is the second biggest and strongest market for orthopedic biomaterials worldwide. Due to the accessibility of innovative therapy equipment and the increasing study activities in nanotechnological orthopedic biomaterials, the European market is anticipated to expand over the forecast era. Furthermore, the development of the orthopedic biomaterials market is being driven by growing instances of orthopedic surgery and increased public health consciousness.
With a CAGR of around 11%, Asia Pacific is anticipated in the prediction era to be the fastest growing regional market. Increasing incidence of bone-degenerative and bone disorders in low and middle-income nations are key factors driving the regional market. In addition, the constant increase in medical spending and improvement in health-care infrastructure is anticipated to drive the market in this region highly.
In the Middle East and Africa, there are some important variables such as the absence of knowledge, restricted access, and accessibility of therapies which are supposed to demonstrate the lowest development. Due to increasing health expenses and the general development of the health-care situation, the United Arab Emirates is also the main market in the Middle East.
Orthopedic Biomaterials Market Players
Some of the top orthopedic biomaterials market companies offered in the professional report include DePuy Synthes Inc., DSM Biomedical, Stryker Corp., Invibio Ltd., AdvanSource Biomaterials Corp., Zimmer Biomet, Globus Medical, Matexcel, Exactech, Inc., CAM Bioceramics B.V., Evonik Industries AG, and Heraeus Holding.
Frequently Asked Questions
The estimated value of global orthopedic biomaterials market in 2021 was accounted to be USD 17,289 Million.
The projected CAGR orthopedic biomaterials market during the analysis period of 2022 to 2030 is 9.7%.
The prominent players of the global orthopedic biomaterials market are DePuy Synthes Inc., DSM Biomedical, Stryker Corp., Invibio Ltd., AdvanSource Biomaterials Corp., Zimmer Biomet, Globus Medical, Matexcel, Exactech, Inc., CAM Bioceramics B.V., Evonik Industries AG, and Heraeus Holding.
North America held the dominating orthopedic biomaterials during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for orthopedic biomaterials during the analysis period of 2022 to 2030.
Increasing occurrences of musculoskeletal ailments, and rising geriatric population across the worldwide drives the growth of global orthopedic biomaterials market.
Based on application, orthopedic implants segment is expected to hold the maximum share orthopedic biomaterials market.
